VerifiedFreedom Diagnostics
99.65%
Purity
Passed full QC panel
- Variant
- Tirzepatide 10mg
- Lot
- TR1001
- Net Peptide Content
- 11.70 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
← Back to Research Library
Valence Labs Research
Tirzepatide
Metabolic Research Peptide
- Compound
- Tirzepatide
- Category
- Research Peptide
- Available Variant
- 10mg
- Research Status
- Research Use Only
Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist extensively studied in human metabolic research. These two signaling pathways play important roles in glucose regulation, appetite, energy intake, and metabolic function.
Large randomized clinical trials have examined tirzepatide across body-weight, glucose, body-composition, and cardiometabolic endpoints, giving it a substantial human clinical evidence base.
Research Areas
GIP & GLP-1 Signaling
Tirzepatide activates both GIP and GLP-1 receptors, allowing researchers to examine the combined metabolic effects of these incretin pathways.
Glucose Regulation
A major area of tirzepatide research involves glucose control and insulin-related metabolic responses.
Appetite & Energy Intake
GLP-1 and GIP signaling are involved in pathways related to appetite, satiety, and energy intake.
Body-Weight Research
Large human clinical trials have investigated changes in body weight during tirzepatide treatment.
Cardiometabolic Research
Studies have examined a range of metabolic measurements beyond body weight, including several cardiometabolic risk factors.
How It Is Being Studied
Tirzepatide has been evaluated in large randomized Phase 3 human clinical trials. The evidence base is considerably more developed than that of many experimental peptides.
The Valence Labs catalog product remains presented for research use; this page summarizes published research and does not provide treatment or administration guidance.
Specifications
Catalog details for this product.
- Product Name
- Tirzepatide
- Category
- Research Peptide
- Variant
- 10mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Certificates of Analysis
VerifiedFreedom Diagnostics
99.87%
Purity
Passed full QC panel
- Variant
- Tirzepatide 20mg
- Lot
- TR2001
- Net Peptide Content
- 23.12 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
VerifiedFreedom Diagnostics
99.81%
Purity
Passed full QC panel
- Variant
- Tirzepatide 30mg
- Lot
- TR3001
- Net Peptide Content
- 32.02 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
References
- Jastreboff et al. — Tirzepatide Once Weekly for the Treatment of Obesity
New England Journal of Medicine / SURMOUNT-1
- SURMOUNT Clinical Trial Program
Available Product
Tirzepatide
10mg